This study evaluates therapeutic efficacy of human mesenchymal stem cell (hMSC) derived treatments applied to an ischemic stroke rat model. The goal is to determine if the presence of hMSC or hMSC derivatives in an ischemic region is required or if delivery of cell secretions alone can improve outcomes, either locally at the lesion or by recruiting regenerative neural progenitor cells. Biochemical markers of tissue recovery measured longitudinally using sodium chemical shift imaging and relaxation-enhanced MR spectroscopy at 21.1 T enables increased sensitivity, enabling insight into ionic and metabolic regulation while enabling to determine therapy efficacy.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords